China Expected To Have H7N9 Bird Flu Vaccine On Market By May
This article was originally published in PharmAsia News
Executive Summary
China is expected to have its home-made H7N9 vaccine approved for the market by May as the number of infections recorded in the country this year reached 120, 36 of them fatal.